ClearPoint Neuro (CLPT) Investor Presentation - Slideshow

Company Overview - ClearPoint Neuro operates with a common installed base platform and clinical specialist support team, targeting over 1 million patients diagnosed annually across 35+ active indications[3] - The company estimates a potential total addressable market exceeding $12 billion[3, 22] - ClearPoint Neuro has established a growing global installed base of over 60 centers[4] and expects to reach 100+ centers by 2025[12] - The company has approximately 45 active Pharma and Academic partners[3, 13] Financial Performance & Model - The company anticipates FY22 revenue of $22 million[14] - A razor/razorblade model generates over 95% of revenue from single-use disposables and services[5] - Capital equipment accounts for approximately 5% of revenue[5] Growth Strategy - A four-pillar growth strategy aims to target indications affecting over 1 million patients diagnosed each year[20] - The company intends to expand its global footprint, launch a robotic platform, and release a digital health patient portal application[20] - ClearPoint Neuro plans to enter the neuro laser ablation market and launch the Maestro Brain Model and therapy apps[20] Market Opportunity - The company identifies a US market opportunity ranging from $42 billion to $208 billion across various neurological indications[16]